CNS FINDINGS IN CONGENITAL MUSCULAR DYSTROPHY 1A (WITH LAMININ ALPHA-2-DEFICIENCY)

被引：0
|
作者：
Koehler, Cornelia [1 ]
Weigt-Usinger, Katharina [1 ]
Heyer, Christoph M. [2 ]
Thiels, Charlotte [1 ]
Dekomien, Gabriele [4 ]
Vorgerd, Matthias [3 ]
Luecke, Thomas [1 ]
机构：
[1] Ruhr Univ Bochum, Univ Childrens Hosp, Dept Neuropediat, Bochum, Germany
[2] Ruhr Univ Bochum, Dept Diagnost Radiol & Nucl Med, Bochum, Germany
[3] Ruhr Univ Bochum, Dept Neurol, Bochum, Germany
[4] Ruhr Univ Bochum, Dept Genet, Bochum, Germany
来源：
TRANSLATIONAL NEUROSCIENCE | 2011年 / 2卷 / 02期
关键词：
Central nervous system; Congenital muscular dystrophy; MRI; White matter lesions; Grey matter lesions; MEROSIN DEFICIENCY; MR SPECTROSCOPY; BRAIN; INVOLVEMENT; POPULATION; EPILEPSY;
D O I：
10.2478/s13380-011-0020-7
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Congenital muscular dystrophy (MDC) is a group of rare hereditary myopathies with an early onset of progressive muscle weakness and dystrophic changes as evidenced by muscle biopsy. Some forms are associated with severe malformations of the brain. This study presented 2 pediatric patients with genetically diagnosed congenital muscular dystrophy 1A. The patients exhibited a typical combination of muscular hypotonia, joint contractures and elevated creatine kinase levels. Characteristic white matter lesions were not present in an early MRI scan of one patient, but could be detected at the age of 18 months. The second patient showed both severe white and grey matter abnormalities (pachy microgyria) in the MRI scan. In both cases, MRI findings did not correlate with the mental development of the patients.
引用
收藏
页码：138 / 141
页数：4
相关论文
共 50 条
  • [1] Congenital muscular dystrophy with primary laminin alpha(2) deficiency presenting as inflammatory myopathy
    Pegoraro, E
    Mancias, P
    Swerdlow, SH
    Raikow, RB
    Angelini, C
    Trevisan, CP
    Garcia, C
    Marks, H
    Crawford, T
    Carver, V
    Hoffman, EP
    NEUROLOGY, 1996, 46 (02) : 8005 - 8005
  • [2] Novel laminin alpha 2 mutations in congenital muscular dystrophy
    Mendell, JT
    Feng, B
    Sahenk, Z
    Marzluf, GA
    Amato, AA
    Mendell, JR
    NEUROLOGY, 1997, 48 (03) : 3135 - 3135
  • [3] A New Laminin a2-Based Gene Therapy for Congenital Muscular Dystrophy 1A
    Packer, Davin
    Martin, Paul T.
    MOLECULAR THERAPY, 2020, 28 (04) : 219 - 219
  • [4] Congenital muscular dystrophy with primary laminin alpha 2 (merosin) deficiency presenting as inflammatory myopathy
    Pegoraro, E
    Mancias, P
    Swerdlow, SH
    Raikow, RB
    Garcia, C
    Marks, H
    Crawford, T
    Carver, V
    DiCianno, B
    Hoffman, EP
    ANNALS OF NEUROLOGY, 1996, 40 (05) : 782 - 791
  • [5] Congenital muscular dystrophy with laminin alpha 2 chain deficiency: Identification of a new intermediate phenotype and correlation of clinical findings to muscle immunohistochemistry
    Herrmann, R
    Straub, V
    Meyer, K
    Kahn, T
    Wagner, M
    Voit, T
    EUROPEAN JOURNAL OF PEDIATRICS, 1996, 155 (11) : 968 - 976
  • [6] Deficiency of merosin (laminin M or alpha 2) in congenital muscular dystrophy associated with cerebral white matter alterations
    Vainzof, M
    Marie, SKN
    Reed, UC
    Schwartzman, JS
    Pavanello, RCM
    PassosBueno, MR
    Zatz, M
    NEUROPEDIATRICS, 1995, 26 (06) : 293 - 297
  • [7] Immunohistochemical study of merosin-negative congenital muscular dystrophy: Laminin alpha 2 deficiency in skin biopsy
    Marbini, A
    Bellanova, MF
    Ferrari, A
    Lodesani, M
    Gemignani, F
    ACTA NEUROPATHOLOGICA, 1997, 94 (02) : 103 - 108
  • [8] Localization of laminin chains in the human retina: Possible implications for congenital muscular dystrophy associated with alpha 2-chain of laminin deficiency
    Toti, P
    DeFelice, C
    Malandrini, A
    Megha, T
    Cardone, C
    Villanova, M
    NEUROMUSCULAR DISORDERS, 1997, 7 (01) : 21 - 25
  • [9] Congenital muscular dystrophy with primary partial laminin α2 chain deficiency:: Molecular study
    He, Y
    Jones, KJ
    Vignier, N
    Morgan, G
    Chevallay, M
    Barois, A
    Estournet-Mathiaud, B
    Hori, H
    Mizuta, T
    Tomé, FMS
    North, KN
    Guicheney, P
    NEUROLOGY, 2001, 57 (07) : 1319 - 1322
  • [10] Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
    Taniguchi, M.
    Kurahashi, H.
    Noguchi, S.
    Sese, J.
    Okinaga, T.
    Tsukahara, T.
    Guicheney, P.
    Ozono, K.
    Nishino, I.
    Morishita, S.
    Toda, T.
    NEUROMUSCULAR DISORDERS, 2006, 16 (9-10) : 683 - 684
12345